These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 28323910)

  • 1. Progressive Development of PTH Resistance in Patients With Inactivating Mutations on the Maternal Allele of GNAS.
    Usardi A; Mamoune A; Nattes E; Carel JC; Rothenbuhler A; Linglart A
    J Clin Endocrinol Metab; 2017 Jun; 102(6):1844-1850. PubMed ID: 28323910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A severe inactivating PTH/PTHrP signaling disorder type 2 in a patient carrying a novel large deletion of the GNAS gene: a case report and review of the literature.
    Brancatella A; Mantovani G; Elli FM; Borsari S; Marcocci C; Cetani F
    Endocrine; 2020 Feb; 67(2):466-472. PubMed ID: 31939093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and Molecular Characteristics of GNAS Inactivation Disorders Observed in 18 Korean Patients.
    Han SR; Lee YA; Shin CH; Yang SW; Lim BC; Cho TJ; Ko JM
    Exp Clin Endocrinol Diabetes; 2021 Feb; 129(2):118-125. PubMed ID: 31546270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant growth hormone improves growth and adult height in patients with maternal inactivating GNAS mutations.
    Ertl DA; de Nanclares GP; Jüppner H; Hanna P; Pagnano A; Pereda A; Rothenbuhler A; Del Sindaco G; Ruiz-Cuevas P; Audrain C; Escribano A; Berkenou J; Gleiss A; Mantovani G; Linglart A
    Eur J Endocrinol; 2023 Jul; 189(1):123-131. PubMed ID: 37440712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Nomenclature of Pseudohypoparathyroidism: Inactivating Parathyroid Hormone/Parathyroid Hormone-Related Protein Signaling Disorder.
    Turan S
    J Clin Res Pediatr Endocrinol; 2017 Dec; 9(Suppl 2):58-68. PubMed ID: 29280743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mild progressive osseous heteroplasia overlap syndrome with PTH and TSH resistance appearing during adolescence and not early childhood.
    Ozaki K; Mituboshi A; Nagai M; Nishiyama A; Nishimura G; Morisada N; Iijima K
    Endocrine; 2021 Dec; 74(3):685-689. PubMed ID: 34254228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel GNAS mutation in a case of pseudohypoparathyroidism type 1A with normocalcemia.
    Long XD; Xiong J; Mo ZH; Dong CS; Jin P
    BMC Med Genet; 2018 Jul; 19(1):132. PubMed ID: 30060753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudohypoparathyroidism: Focus on Cerebral and Renal Calcifications.
    Mazoni L; Apicella M; Saponaro F; Mantovani G; Elli FM; Borsari S; Pardi E; Piaggi P; Marcocci C; Cetani F
    J Clin Endocrinol Metab; 2021 Jul; 106(8):e3005-e3020. PubMed ID: 33780542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of Multiple Families With Single Individuals Affected by Pseudohypoparathyroidism Type Ib (PHP1B) Reveals Only One Novel Maternally Inherited GNAS Deletion.
    Takatani R; Molinaro A; Grigelioniene G; Tafaj O; Watanabe T; Reyes M; Sharma A; Singhal V; Raymond FL; Linglart A; Jüppner H
    J Bone Miner Res; 2016 Apr; 31(4):796-805. PubMed ID: 26479409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compound heterozygous mutations in the GNAS gene of a boy with morbid obesity, thyroid-stimulating hormone resistance, pseudohypoparathyroidism, and a prothrombotic state.
    Freson K; Izzi B; Jaeken J; Van Helvoirt M; Thys C; Wittevrongel C; de Zegher F; Van Geet C
    J Clin Endocrinol Metab; 2008 Dec; 93(12):4844-9. PubMed ID: 18796523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Paternal GNAS mutations: Which phenotypes? What genetic counseling?].
    Kottler ML
    Ann Endocrinol (Paris); 2015 May; 76(2):105-9. PubMed ID: 25952723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and approach of pseudohypoparathyroidism type 1A and related disorders during long term follow-up: a case report.
    Expósito Raspeño M; Sánchez Escudero V; Pérez de Nanclares Leal G; Ortiz Santamaría M; Sánchez-Dehesa Sáez R; García Cuartero B; González Vergaz A
    J Pediatr Endocrinol Metab; 2024 Mar; 37(3):289-295. PubMed ID: 38353264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel deletion involving GNAS exon 1 causes PHP1A and further refines the region required for normal methylation at exon A/B.
    Reyes M; Karaca A; Bastepe M; Gulcelik NE; Jüppner H
    Bone; 2017 Oct; 103():281-286. PubMed ID: 28711660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and management of congenital hypothyroidism associated with pseudohypoparathyroidism.
    Picard C; Decrequy A; Guenet D; Bursztejn AC; Toledano D; Richard N; Kottler ML
    Horm Res Paediatr; 2015; 83(2):111-7. PubMed ID: 25591844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression of PTH Resistance in Autosomal Dominant Pseudohypoparathyroidism Type Ib Due to Maternal STX16 Deletions.
    Kiuchi Z; Reyes M; Hanna P; Sharma A; DeClue T; Olney RC; Tebben P; Jüppner H
    J Clin Endocrinol Metab; 2022 Jan; 107(2):e681-e687. PubMed ID: 34477200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel GNAS mutation inherited from probable maternal mosaicism causes two siblings with pseudohypoparathyroidism type 1A.
    Wang Q; Xian J; Chen P; Wang J; Gao Y; Zheng X; Tan Z; Li C; Zeng K
    J Pediatr Endocrinol Metab; 2020 Sep; 33(9):1219-1224. PubMed ID: 32866120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Large Inversion Involving GNAS Exon A/B and All Exons Encoding Gsα Is Associated With Autosomal Dominant Pseudohypoparathyroidism Type Ib (PHP1B).
    Grigelioniene G; Nevalainen PI; Reyes M; Thiele S; Tafaj O; Molinaro A; Takatani R; Ala-Houhala M; Nilsson D; Eisfeldt J; Lindstrand A; Kottler ML; Mäkitie O; Jüppner H
    J Bone Miner Res; 2017 Apr; 32(4):776-783. PubMed ID: 28084650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal and Early Infancy Features of Patients With Inactivating PTH/PTHrP Signaling Disorders/Pseudohypoparathyroidism.
    Del Sindaco G; Berkenou J; Pagnano A; Rothenbuhler A; Arosio M; Mantovani G; Linglart A
    J Clin Endocrinol Metab; 2023 Oct; 108(11):2961-2969. PubMed ID: 37098127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preferential Maternal Transmission of STX16-GNAS Mutations Responsible for Autosomal Dominant Pseudohypoparathyroidism Type Ib (PHP1B): Another Example of Transmission Ratio Distortion.
    Kiuchi Z; Reyes M; Jüppner H
    J Bone Miner Res; 2021 Apr; 36(4):696-703. PubMed ID: 33247854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venous Thrombosis in a Pseudohypoparathyroidism Patient with a Novel GNAS Frameshift Mutation and Complete Resolution of Vascular Calcifications with Acetazolamide Treatment.
    Seven Menevse T; Iwasaki Y; Yavas Abali Z; Gurpinar Tosun B; Helvacioglu D; Dogru Ö; Bugdayci O; Cyr SM; Güran T; Bereket A; Bastepe M; Turan S
    Horm Res Paediatr; 2024; 97(4):404-415. PubMed ID: 37906994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.